Table 5 Summary of drug therapies
From: Damage index in childhood-onset systemic lupus erythematosus in Egypt
Medication | % of patients who received the therapy |
|---|---|
Antimalarial medications, either daily or 3 times weekly | 83.0% |
Oral prednisone, either daily or alternate day | 97.8% |
Intravenous methylprednisolone pulses (30 mg/kg) at any time during disease course | 67.7% |
Cyclophosphamide pulses (500-1000 mg/m2) | 42% |
Azathioprine | 45% |
Mycofenolate mofetil | 8% |
Cyclosporine | 3% |